Restoring mismatch repair does not stop the formation of reciprocal translocations in the colon cancer cell line HCA7 but further destabilizes chromosome number

Oncogene

Volumn 24, Issue 4, 2005, Pages 706-713

  Abdel Rahman, Wael M ^a,b   Lohi, Hannes ^a   Knuutila, Sakari ^a   Peltomäki, Päivi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Zagazig University   (Egypt)

Author keywords

Mismatch repair; MLH1; Radiation; Reciprocal translocations; Recombination

Indexed keywords

AZACITIDINE; DOUBLE STRANDED DNA;

ARTICLE; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CHROMOSOMAL INSTABILITY; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; COLON CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA STRAND BREAKAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMA IRRADIATION; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC RECOMBINATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; MISMATCH REPAIR; MULTIPLEX FLUORESCENCE IN SITU HYBRIDIZATION; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPROCAL CHROMOSOME TRANSLOCATION;

CARRIER PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN; COLONIC NEOPLASMS; DNA REPAIR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSLOCATION, GENETIC;

EID: 13244283011     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208129     Document Type: Article

References (34)

1. Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, Bicknell D, Bodmer WF, Arenas MJ, Wyllie AH and Edwards PAW. (2001). Proc. Natl. Acad. Sci. USA, 98, 2538-2543.
2. Bardelli A, Cahill CP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B and Lengauer C. (2001). Proc. Natl. Acad. Sci. USA, 98, 5770-5775.
3. Bocker T, Schlegel J, Kullmann F, Stumm G, Zirngibl H, Epplen JT and Ruschoff J. (1996). J. Pathol., 179, 15-19.
4. Buermeyer AB, Wilson-Van Patten C, Baker SM and Liskay M. (1999). Cancer Res., 59, 538-541.
5. Chan TL, Curtis LC, Leung SY, Farrington SM, Ho JW, Chan ASY, Lam PWY, Tse CW, Dunlop MG, Wyllie AH and Yuen ST. (2001). Oncogene, 20, 4871-4876.
6. Chauveinc L, Dutrillaux AM, Validire P, Padoy E, Sabatier L, Couturier J and Dutrillaux B. (1999). Cancer Genet. Cytogenet., 114, 1-8.
7. Ciotta C, Ceccotti S, Aquilina G, Humbert O, Palombo F, Jiricny J and Bignami M. (1998). J. Mol. Biol., 276, 705-719.
8. de Wind N, Dekker M, Berns A, Radman M and Riele HT. (1995). Cell, 82, 321-330.
9. Deans B, Griffin CS., O'Regan P, Jasin M and Thacker J. (2003). Cancer Res., 63, 8181-8187.
10. Dutrillaux B. (1995). Adv. Cancer Res., 67, 59-82.
11. Elliott B and Jasin M. (2001). Mol. Cell. Biol., 21, 2671-2682.
12. Eshleman JR, Casey G, Kochera ME, Sedwick WD, Swinler SE, Veigl ML, Willson JKV, Schwartz S and Markowitz SD. (1998). Oncogene, 17, 719-725.
13. Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao YJ, DePinho RA and Alt FW. (2000). Proc. Natl. Acad. Sci. USA, 97, 6630-6633.
14. Georgiades IB, Curtis LJ, Morris RM, Bird CC and Wyllie AH. (1999). Oncogene, 18, 7933-7940.
15. Giannini G, Ristori E, Cerignoli F, Rinaldi C, Zani M, Viel A, Ottini L, Crescenzi M, Martinotti S, Bignami M, Frati L, Screpanti I and Gulino A. (2002). EMBO Rep., 3, 248-254.
16. Harfe BD and Jinks-Robertson S. (2000). Mutat. Res.-Fund. Mol. M., 451, 151-167.
17. Jasin M. (2000). Cancer Invest., 18, 78-86.
18. Kim NG, Choi YR, Back MJ, Kim YH, Kang H, Kim NK, Min JS and Kim H. (2001). Cancer Res., 61, 36-38.
19. Lambert B, Holmberg K, Hackman P and Wennborg A. (1998). Mutat. Res., 405, 161-170.
20. Lefevre SH, Vogt N, Dutrillaux AM, Chauveinc K, Stoppa-Lyonnet D, Doz F, Desjardins L, Dutrillaux B, Chevillard S and Malfoy B. (2001). Oncogene, 20, 8092-8099.
21. Limoli CL, Corcoran JJ, Jordan R, Morgan WF and Schwartz JL. (2001). Br. J. Cancer, 84, 489-492.
22. Moynahan ME, Cui TY and Jasin M. (2001). Cancer Res., 61, 4842-4850.
23. Peltomäki P. (2001). Mutat. Res.-Rev. Mutat. Res., 488, 77-85.
24. Richardson C and Jasin M. (2000). Nature, 405, 697-700.
25. Richardson C, Stark JM, Ommundsen M and Jasin M. (2004). Oncogene, 23, 546-553.
26. Risinger JI, Umar A, Glaab WE, Tindall KR, Kunkel TA and Barren JC. (1998). Cancer Res., 58, 2978-2981.
27. Roschke AV, Stover K, Tonon G, Schaffer AA and Kirsch IR. (2002). Neoplasia, 4, 19-31.
28. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J and Hofstadter F. (1995). Cancer Res., 55, 6002-6005.
29. Schweizer P, Moisio AL, Kuismanen SA, Truninger K, Vierumaki R, Salovaara R, Arola J, Butzow R, Jiricny J, Peltomäki P and Nyström-Lahti M. (2001). Cancer Res., 61, 2813-2815.
30. Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y and Takeda S. (1998). EMBO J., 17, 598-608.
31. Szostak JW, Orrweaver TL and Rothstein RJ. (1983). Cell, 33, 25-35.
32. Tsuji T, Sawai T, Nakagoe T, Hidaka S, Shibasaki S, Tanaka K, Nanashima A, Yamaguchi H, Yasutake T and Tagawa Y. (2003). J. Gastroenterol, 38, 1185-1188.
33. Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ and Bodmer WF. (1999). Proc. Natl. Acad. Sci. USA, 96, 10296-10301.
34. Yu V, Koehler M, Steinlein C, Schmid M, Hanakahi LA, van Gool AJ, West SC and Venkitaraman AR. (2000). Gene Dev., 14, 1400-1406.